Shares of health insurers lost ground Wednesday as executives at Centene (CNC) warned about a pullback in the number of people receiving Medicaid benefits.
Shares of major players in the Medicaid business dropped sharply Wednesday after Centene Corp. executives spoke about ongoing tumult in the joint federal and state program.
CNC gains from improved premiums and service revenues, acquisitions and adequate operating cash flows.
The relocation of the facility is expected to enhance CNC's specialty pharmacy capabilities and patient care services.
Centene Corporation is a financially healthy company but is assessed a Hold opportunity for retail value investors due to political uncertainties about government healthcare programs and lack of a dividend. Despite a positive Q2 '24 earnings report, Centene stock has exhibited high volatility and faces growth challenges. Risks for investors include reliance on government programs, potential regulatory changes, and limited growth opportunities in the healthcare sector.
Centene has a 10-year price return of 313.77%, almost double the 179.34% price return of the S&P 500. The company is strategically positioned in the market, and the current favorable trends serve as major growth levers. The stock is undervalued, making it a decent buy.
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Centene (CNC) shares jumped in intraday trading Friday as the managed care provider reported better-than-expected profit and sales and raised its guidance as its premium and services sales and members increased.
Centene's (CNC) second-quarter earnings suffer from rising operating expenses and a decline in Medicaid membership levels. Improved Marketplace membership growth partially offset the negatives.
The headline numbers for Centene (CNC) give insight into how the company performed in the quarter ended June 2024, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
On Friday, Centene Corporation CNC reported second-quarter sales of $39.84 billion, up 5.9% year-over-year, beating the consensus of $36.46 billion.
Centene (CNC) came out with quarterly earnings of $2.42 per share, missing the Zacks Consensus Estimate of $2.44 per share. This compares to earnings of $2.10 per share a year ago.